234 related articles for article (PubMed ID: 6270842)
1. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
2. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
3. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
Bonne C; Martin B; Watada M; Regnault F
Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
[No Abstract] [Full Text] [Related]
4. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
5. Heparin neutralization of PGI2: effects upon platelets.
Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
[TBL] [Abstract][Full Text] [Related]
6. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
7. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
Johnson GJ; Rao GH; Leis LA; White JG
Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
[No Abstract] [Full Text] [Related]
8. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
9. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
Takano S; Itagaki S; Sakurai K; Suzuki T
Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
[TBL] [Abstract][Full Text] [Related]
10. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
11. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
[TBL] [Abstract][Full Text] [Related]
12. Roles of cyclic nucleotides in platelet function.
Haslam RJ
Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
[No Abstract] [Full Text] [Related]
13. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
Reches A; Eldor A; Salomon Y
Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
[No Abstract] [Full Text] [Related]
14. Pharmacology of platelet-suppressive agents.
Wautier JL; Caen JP
Semin Thromb Hemost; 1979; 5(4):293-315. PubMed ID: 386519
[No Abstract] [Full Text] [Related]
15. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
16. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
Kindness G; Williamson FB; Long WF
Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
[No Abstract] [Full Text] [Related]
17. [Platelet suppressive drugs (author's transl)].
Shio H; Kameyama M
No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
[No Abstract] [Full Text] [Related]
18. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
[No Abstract] [Full Text] [Related]
20. The cyclic AMP-lowering effect on the stable endoperoxide analog U46619 in human platelets.
Bonne C; Martin B; Regnault F
Thromb Res; 1980 Dec 1-15; 20(5-6):701-4. PubMed ID: 6262941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
